Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Study Phase
Phase 3
Study Completion Date
January 2007
NCT00119613Uploaded 08-03-2018
Available for Download
PDS UID: LungSm_Amgen_2002_266
A Randomized, Double Blind, Placebo-Controlled Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa
PROTOCOL20010145_01.20.01 Protocol Amend 2 2004-07-16 English_Redacted.pdf
CRFAmgen 20010145 DDT - v2.pdf
DATA DICTIONARYAmgen 20010145 DDT.pdf
OTHERAmgen 20010145 CRF PRO.pdf